Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.

JCI Insight · 2026 · PMC12892910 · PMID 41364531

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All intratumoral T cell subsets in the CD155 hi cohort showed a trend toward increased CD226 expression.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.